Vaxfab Enterprises Ltd

Vaxfab Enterprises Limited has appointed M/s. ASGM & Co., Chartered Accountants, for an independent forensic accounting and investigation engagement covering the financial years ended March 31, 2023, March 31, 2024, and March 31, 2025, the company said in a filing on November 3, 2026. The audit follows a transition of management in April 2025, where historical financial records were not fully handed over, and concerns arose regarding GST notices and queries related to historical transactions. The engagement will include examination of financial records, verification of transactions, and assessment of internal controls, with a professional fee of Rs 300,000 plus applicable taxes and expenses.

Vaxfab Enterprises Limited plans to raise up to Rs 45,00,00,000 through a rights issue of equity shares with a face value of Rs 10 each, offering the securities to eligible shareholders on a yet-to-be-determined price and entitlement ratio. The board approved the rights issue, along with a draft letter of offer and the formation of a Rights Issue Committee consisting of Mr. Ravindra Ashokbhai Joshi (Chairman), Mr. Jinang Dineshkumar Shah (Member), and Ms. Juhi Sawajani (Member), authorizing them to appoint intermediaries and handle related matters. The board meeting commenced at 4:00 PM and concluded at 4:30 PM on October 1, 2026.

Vaxfab Enterprises Limited will close its trading window for all designated persons, including directors and promoters, from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter ended September 30, 2026, in accordance with its insider trading policy and SEBI regulations.

Vaxfab Enterprises Limited will seek to augment its financial resources through a fundraising exercise involving the issuance of equity shares, convertible instruments, or other securities via preferential allotment, right issue, QIP’s, ADR GDR, FCCB or any other method or combination thereof, the company said in a filing with the BSE Limited and The Calcutta Stock Exchange Limited on September 25, 2026. The company’s trading window for securities has been closed from September 25, 2026, and will remain so until 48 hours after the conclusion of the board meeting scheduled for October 1, 2026.

Vaxfab Enterprises Limited approved an increase in its authorized share capital from Rs 35 crore divided into 3,47,00,000 equity shares and 3,00,000 preference shares to Rs 50 crore divided into 4,97,00,000 equity shares and 3,00,000 preference shares, according to a regulatory filing on Thursday. The company’s board also decided to hold its 43rd Annual General Meeting on September 29, 2026, at 12:00 P.M. at its registered office in Ahmedabad, and appointed Mrs. Shubhangi Rajkumar Agarwal as the scrutinizer for the voting process.

Vaxfab Enterprises Limited announced the allotment of 8,26,761 equity shares at a price of Rs 21.02 per share to investors following the conversion of warrants, increasing the company's paid-up equity share capital to Rs 25,82,64,060 comprising 2,58,26,406 equity shares. The allotment involved nine investors, with ASHWINKUMA R DANABHAI CHAUHAN, BHAVIN KANJIBHAI CHARIA, CHEHARABHAI SARTANBHAI RABARI, DESAI DEEPAK BABUBHAI, VYAS HARENDRA JAGDISHBHAI, CHAVDA VALJIBHAI PITAMBARBHAI, RANJITSINH KANUBHAI GOHEL, SANJAY VINODBHAI CHAUHAN, and HEMA HARDIK PARIKH participating in the conversion.

Vaxfab Enterprises Limited announced the allotment of 8,26,761 equity shares with a face value of Rs 10 each at a price of Rs 21.02 per share to nine investors following the conversion of warrants, increasing the company's paid-up equity share capital to Rs 25,82,64,060 comprising 2,58,26,406 equity shares.

Vaxfab Enterprises Limited has incorporated a wholly owned subsidiary, Al Rafa Enterprise FZ-LLC, in the United Arab Emirates on August 6, 2026, with an initial capital of AED 1,000 per share. The company received the Certificate of Incorporation and other legal documents on August 11, 2026, prompting the filing of the disclosure with the BSE Limited and The Calcutta Stock Exchange Limited.

Vaxfab Enterprises Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, the company said in a filing. The trading window for company insiders has been closed since July 1, 2026, and will remain so until 48 hours after the results are submitted.

Net profit of Vaxfab Enterprises rose 68.72% to Rs 3.02 crore in the quarter ended March 2026 as against Rs 1.79 crore during the previous quarter ended March 2025. Sales rose 176.80% to Rs 8.83 crore in the quarter ended March 2026 as against Rs 3.19 crore during the previous quarter ended March 2025. For the full year,net profit rose 527.59% to Rs 3.64 crore in the year ended March 2026 as against Rs 0.58 crore during the previous year ended March 2025. Sales rose 60.41% to Rs 94.11 crore in the year ended March 2026 as against Rs 58.67 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales8.833.19 177 94.1158.67 60 OPM %-28.8858.62 --0.310.03 - PBDT6.981.92 264 5.200.73 612 PBT6.971.91 265 5.170.70 639 NP3.021.79 69 3.640.58 528 Powered by Capital Market - Live